Ameritas Investment Partners, Inc. Athenex, Inc. Transaction History

Ameritas Investment Partners, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.41 - $0.91 $2,456 - $5,451	-5,991 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$11.06 - $14.01 $7,852 - $9,947	710 Added 13.44%	5,991 $66,000
Q3 2020 Nov 13, 2020	SELL	$10.26 - $14.55 $12,547 - $17,794	-1,223 Reduced 18.8%	5,281 $64,000
Q2 2020 Aug 05, 2020	BUY	$7.11 - $13.76 $5,872 - $11,365	826 Added 14.55%	6,504 $89,000
Q3 2019 Nov 14, 2019	BUY	$12.16 - $21.0 $7,198 - $12,432	592 Added 11.64%	5,678 $69,000
Q2 2019 Aug 14, 2019	BUY	$9.44 - $19.8 $14,707 - $30,848	1,558 Added 44.16%	5,086 $101,000
Q2 2018 Aug 13, 2018	BUY	$15.88 - $19.5 $46,591 - $57,213	2,934 Added 493.94%	3,528 $66,000
Q4 2017 Feb 14, 2018	BUY	$14.41 - $19.15 $8,559 - $11,375	594	594 $9,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.